000 02691cam a2200349 a 4500
003 EG-GiCUC
005 20250223032629.0
008 201115s2020 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.12.02.Ph.D.2020.Mo.R
100 0 _aMohamed Attia Ragheb Erfan
245 1 0 _aRegulation of doxorubicin chemotherapeutic potential by MiR-520c-3p in hepatocellular carcinoma cells /
_cMohamed Attia Ragheb Erfan ; Supervised Mervat Elsayed Mohamed , Emad Mahmoud Ibrahim Elzayat , Abdelhady Ali Abdelwahab
246 1 _aفى خلايا سرطان الكبد (MiR-520c-3p)تنظيم الامكانية العلاجية للدكسوروبيسين عن طريق الحمض الميكروريبوزى النووى
260 _aCairo :
_bMohamed Attia Ragheb Erfan ,
_c2020
300 _a160 P . :
_bcharts , facsmilies ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry
520 _aBackground: Doxorubicin (Dox) is one of the most common drugs used in cancer therapy, including hepatocellular carcinoma (HCC). Drug resistance, is one of chemotherapy{u2019}s significant problems. Emerging studies have shown that microRNAs (miRNAs) could participate in regulating this mechanism. Nevertheless, the impact of miRNAs on HCC chemoresistance is still enigmatic. Objective: Investigating the role of a candidate miRNA in enhancement of anti-tumor effects of Dox against HepG2 cells. Expression profile for liver related miRNAs (384 miRNAs) has been analyzed on HepG2 cells treated with Dox using qRT-PCR. miR- 520c-3p, the most deregulated miRNA, was selected for combination treatment with Dox. Methods: Expression level for LEF1, CDK2, CDH1, VIM, Mcl-1 and p53 was evaluated in miR-520c-3p transfected cells. Cell viability, colony formation, wound healing as well as apoptosis assays have been demonstrated. Furthermore, Mcl-1 protein level was measured using a western blot technique. Results: The present data indicates that miR-520c-3p overexpression could render HepG2 cells chemo-sensitive to Dox through enhancing its suppressive effects on proliferation, migration, and induction of apoptosis
530 _aIssued also as CD
653 4 _aChemosensitivity
653 4 _aHepatocellular carcinoma
653 4 _amiR-520c-3p
700 0 _aAbdelhady Ali Abdelwahab ,
_eSupervisor
700 0 _aEmad Mahmoud Ibrahim Elzayat ,
_eSupervisor
700 0 _aMervat Elsayed Mohamed ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aAmira
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c78767
_d78767